nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—ALB—chronic obstructive pulmonary disease	0.289	1	CbGaD
Nateglinide—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.0795	0.175	CbGbCtD
Nateglinide—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0422	0.0927	CbGbCtD
Nateglinide—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0422	0.0927	CbGbCtD
Nateglinide—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0386	0.0848	CbGbCtD
Nateglinide—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0386	0.0848	CbGbCtD
Nateglinide—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0344	0.0756	CbGbCtD
Nateglinide—ALB—Prednisone—chronic obstructive pulmonary disease	0.0329	0.0722	CbGbCtD
Nateglinide—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0324	0.0711	CbGbCtD
Nateglinide—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.032	0.0703	CbGbCtD
Nateglinide—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0219	0.048	CbGbCtD
Nateglinide—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0209	0.0458	CbGbCtD
Nateglinide—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0186	0.0409	CbGbCtD
Nateglinide—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0109	0.024	CbGbCtD
Nateglinide—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0103	0.0226	CbGbCtD
Nateglinide—Hepatitis cholestatic—Montelukast—chronic obstructive pulmonary disease	0.00422	0.0268	CcSEcCtD
Nateglinide—Trauma—Arformoterol—chronic obstructive pulmonary disease	0.00364	0.0232	CcSEcCtD
Nateglinide—Trauma—Formoterol—chronic obstructive pulmonary disease	0.00364	0.0232	CcSEcCtD
Nateglinide—Trauma—Montelukast—chronic obstructive pulmonary disease	0.00357	0.0227	CcSEcCtD
Nateglinide—Gastrointestinal symptom NOS—Salbutamol—chronic obstructive pulmonary disease	0.00278	0.0177	CcSEcCtD
Nateglinide—Influenza—Roflumilast—chronic obstructive pulmonary disease	0.00214	0.0136	CcSEcCtD
Nateglinide—Trauma—Prednisolone—chronic obstructive pulmonary disease	0.00197	0.0125	CcSEcCtD
Nateglinide—Polyuria—Aminophylline—chronic obstructive pulmonary disease	0.00188	0.012	CcSEcCtD
Nateglinide—Hepatobiliary disease—Roflumilast—chronic obstructive pulmonary disease	0.00181	0.0115	CcSEcCtD
Nateglinide—Immune system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00155	0.00985	CcSEcCtD
Nateglinide—Malnutrition—Roflumilast—chronic obstructive pulmonary disease	0.00149	0.0095	CcSEcCtD
Nateglinide—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.00144	0.00919	CcSEcCtD
Nateglinide—Trauma—Prednisone—chronic obstructive pulmonary disease	0.00143	0.00911	CcSEcCtD
Nateglinide—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.0014	0.0089	CcSEcCtD
Nateglinide—Injury—Arformoterol—chronic obstructive pulmonary disease	0.00137	0.00871	CcSEcCtD
Nateglinide—Injury—Formoterol—chronic obstructive pulmonary disease	0.00137	0.00871	CcSEcCtD
Nateglinide—Injury—Montelukast—chronic obstructive pulmonary disease	0.00134	0.00853	CcSEcCtD
Nateglinide—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.00132	0.00839	CcSEcCtD
Nateglinide—Thirst—Montelukast—chronic obstructive pulmonary disease	0.00129	0.00824	CcSEcCtD
Nateglinide—Injury—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.00822	CcSEcCtD
Nateglinide—Hypoglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.00129	0.0082	CcSEcCtD
Nateglinide—Hypoglycaemia—Formoterol—chronic obstructive pulmonary disease	0.00129	0.0082	CcSEcCtD
Nateglinide—Increased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00126	0.00804	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Tiotropium—chronic obstructive pulmonary disease	0.00125	0.00797	CcSEcCtD
Nateglinide—Hypoglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.00122	0.00774	CcSEcCtD
Nateglinide—PPARG—leg—chronic obstructive pulmonary disease	0.00111	0.249	CbGeAlD
Nateglinide—Influenza—Arformoterol—chronic obstructive pulmonary disease	0.00109	0.00692	CcSEcCtD
Nateglinide—Influenza—Formoterol—chronic obstructive pulmonary disease	0.00109	0.00692	CcSEcCtD
Nateglinide—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00107	0.00682	CcSEcCtD
Nateglinide—Influenza—Montelukast—chronic obstructive pulmonary disease	0.00107	0.00678	CcSEcCtD
Nateglinide—Oedema peripheral—Tiotropium—chronic obstructive pulmonary disease	0.00106	0.00676	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00105	0.00669	CcSEcCtD
Nateglinide—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00105	0.00668	CcSEcCtD
Nateglinide—Bronchitis—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00665	CcSEcCtD
Nateglinide—Bronchitis—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00665	CcSEcCtD
Nateglinide—Arthropathy—Prednisolone—chronic obstructive pulmonary disease	0.00103	0.00657	CcSEcCtD
Nateglinide—Influenza—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00653	CcSEcCtD
Nateglinide—Bronchitis—Montelukast—chronic obstructive pulmonary disease	0.00102	0.00652	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Formoterol—chronic obstructive pulmonary disease	0.00101	0.00643	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.00643	CcSEcCtD
Nateglinide—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.001	0.00636	CcSEcCtD
Nateglinide—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000996	0.00634	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Montelukast—chronic obstructive pulmonary disease	0.00099	0.0063	CcSEcCtD
Nateglinide—Bronchitis—Salbutamol—chronic obstructive pulmonary disease	0.000988	0.00628	CcSEcCtD
Nateglinide—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000974	0.0062	CcSEcCtD
Nateglinide—Spirapril—ACE—chronic obstructive pulmonary disease	0.000969	0.142	CrCbGaD
Nateglinide—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000968	0.00616	CcSEcCtD
Nateglinide—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000963	0.00613	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Salbutamol—chronic obstructive pulmonary disease	0.000954	0.00607	CcSEcCtD
Nateglinide—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.000939	0.00597	CcSEcCtD
Nateglinide—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000933	0.00593	CcSEcCtD
Nateglinide—Neuropathy peripheral—Montelukast—chronic obstructive pulmonary disease	0.000931	0.00592	CcSEcCtD
Nateglinide—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.000926	0.00589	CcSEcCtD
Nateglinide—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.000908	0.00578	CcSEcCtD
Nateglinide—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.000898	0.00571	CcSEcCtD
Nateglinide—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000898	0.00571	CcSEcCtD
Nateglinide—Neuropathy peripheral—Salbutamol—chronic obstructive pulmonary disease	0.000897	0.00571	CcSEcCtD
Nateglinide—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.000892	0.00568	CcSEcCtD
Nateglinide—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.00088	0.0056	CcSEcCtD
Nateglinide—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.000878	0.00558	CcSEcCtD
Nateglinide—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000874	0.00556	CcSEcCtD
Nateglinide—Cilazapril—ACE—chronic obstructive pulmonary disease	0.000864	0.127	CrCbGaD
Nateglinide—Lisinopril—ACE—chronic obstructive pulmonary disease	0.000864	0.127	CrCbGaD
Nateglinide—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.000857	0.00545	CcSEcCtD
Nateglinide—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.000857	0.00545	CcSEcCtD
Nateglinide—Trandolapril—ACE—chronic obstructive pulmonary disease	0.000837	0.123	CrCbGaD
Nateglinide—Ramipril—ACE—chronic obstructive pulmonary disease	0.000837	0.123	CrCbGaD
Nateglinide—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000834	0.0053	CcSEcCtD
Nateglinide—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00083	0.00528	CcSEcCtD
Nateglinide—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000819	0.00521	CcSEcCtD
Nateglinide—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000806	0.00513	CcSEcCtD
Nateglinide—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000806	0.00513	CcSEcCtD
Nateglinide—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000786	0.005	CcSEcCtD
Nateglinide—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000786	0.005	CcSEcCtD
Nateglinide—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000775	0.00493	CcSEcCtD
Nateglinide—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00077	0.0049	CcSEcCtD
Nateglinide—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000768	0.00489	CcSEcCtD
Nateglinide—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000768	0.00488	CcSEcCtD
Nateglinide—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000758	0.00482	CcSEcCtD
Nateglinide—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000758	0.00482	CcSEcCtD
Nateglinide—Arthropathy—Prednisone—chronic obstructive pulmonary disease	0.00075	0.00477	CcSEcCtD
Nateglinide—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000742	0.00472	CcSEcCtD
Nateglinide—Injury—Prednisolone—chronic obstructive pulmonary disease	0.000741	0.00472	CcSEcCtD
Nateglinide—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000733	0.00466	CcSEcCtD
Nateglinide—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000733	0.00466	CcSEcCtD
Nateglinide—Increased appetite—Prednisolone—chronic obstructive pulmonary disease	0.000725	0.00461	CcSEcCtD
Nateglinide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000724	0.0046	CcSEcCtD
Nateglinide—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000715	0.00455	CcSEcCtD
Nateglinide—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000715	0.00455	CcSEcCtD
Nateglinide—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00071	0.00452	CcSEcCtD
Nateglinide—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00071	0.00452	CcSEcCtD
Nateglinide—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000695	0.00442	CcSEcCtD
Nateglinide—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000692	0.0044	CcSEcCtD
Nateglinide—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	0.000681	0.00433	CcSEcCtD
Nateglinide—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000675	0.00429	CcSEcCtD
Nateglinide—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00067	0.00426	CcSEcCtD
Nateglinide—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00067	0.00426	CcSEcCtD
Nateglinide—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00067	0.00426	CcSEcCtD
Nateglinide—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000664	0.00423	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000662	0.00421	CcSEcCtD
Nateglinide—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000661	0.00421	CcSEcCtD
Nateglinide—Cough—Formoterol—chronic obstructive pulmonary disease	0.000661	0.00421	CcSEcCtD
Nateglinide—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000656	0.00417	CcSEcCtD
Nateglinide—Cough—Montelukast—chronic obstructive pulmonary disease	0.000648	0.00412	CcSEcCtD
Nateglinide—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000646	0.00411	CcSEcCtD
Nateglinide—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000642	0.00409	CcSEcCtD
Nateglinide—Enalapril—ACE—chronic obstructive pulmonary disease	0.000634	0.0929	CrCbGaD
Nateglinide—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000632	0.00402	CcSEcCtD
Nateglinide—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000627	0.00399	CcSEcCtD
Nateglinide—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000624	0.00397	CcSEcCtD
Nateglinide—Bortezomib—CYP1A1—chronic obstructive pulmonary disease	0.00062	0.0909	CrCbGaD
Nateglinide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000609	0.00387	CcSEcCtD
Nateglinide—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000606	0.00385	CcSEcCtD
Nateglinide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000599	0.00381	CcSEcCtD
Nateglinide—Bortezomib—CYP1A2—chronic obstructive pulmonary disease	0.000598	0.0876	CrCbGaD
Nateglinide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000575	0.00366	CcSEcCtD
Nateglinide—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000574	0.00365	CcSEcCtD
Nateglinide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000565	0.00359	CcSEcCtD
Nateglinide—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000564	0.00359	CcSEcCtD
Nateglinide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000556	0.00354	CcSEcCtD
Nateglinide—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000544	0.00346	CcSEcCtD
Nateglinide—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000544	0.00346	CcSEcCtD
Nateglinide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000542	0.00345	CcSEcCtD
Nateglinide—Injury—Prednisone—chronic obstructive pulmonary disease	0.000539	0.00343	CcSEcCtD
Nateglinide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000537	0.00342	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000534	0.0034	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000534	0.0034	CcSEcCtD
Nateglinide—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000533	0.00339	CcSEcCtD
Nateglinide—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000533	0.00339	CcSEcCtD
Nateglinide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000533	0.00339	CcSEcCtD
Nateglinide—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000527	0.00335	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000523	0.00333	CcSEcCtD
Nateglinide—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000522	0.00332	CcSEcCtD
Nateglinide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000517	0.00329	CcSEcCtD
Nateglinide—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000515	0.00327	CcSEcCtD
Nateglinide—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000514	0.00327	CcSEcCtD
Nateglinide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000512	0.00326	CcSEcCtD
Nateglinide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000512	0.00326	CcSEcCtD
Nateglinide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000507	0.00322	CcSEcCtD
Nateglinide—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000506	0.00322	CcSEcCtD
Nateglinide—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000506	0.00322	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000504	0.00321	CcSEcCtD
Nateglinide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000503	0.0032	CcSEcCtD
Nateglinide—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000495	0.00315	CcSEcCtD
Nateglinide—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000495	0.00315	CcSEcCtD
Nateglinide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000491	0.00313	CcSEcCtD
Nateglinide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000491	0.00313	CcSEcCtD
Nateglinide—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000489	0.00311	CcSEcCtD
Nateglinide—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000489	0.00311	CcSEcCtD
Nateglinide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000487	0.0031	CcSEcCtD
Nateglinide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000483	0.00307	CcSEcCtD
Nateglinide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000483	0.00307	CcSEcCtD
Nateglinide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000483	0.00307	CcSEcCtD
Nateglinide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000481	0.00306	CcSEcCtD
Nateglinide—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000479	0.00305	CcSEcCtD
Nateglinide—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000477	0.00304	CcSEcCtD
Nateglinide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000464	0.00295	CcSEcCtD
Nateglinide—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000462	0.00294	CcSEcCtD
Nateglinide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000456	0.0029	CcSEcCtD
Nateglinide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000456	0.0029	CcSEcCtD
Nateglinide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000455	0.0029	CcSEcCtD
Nateglinide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000446	0.00284	CcSEcCtD
Nateglinide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000444	0.00282	CcSEcCtD
Nateglinide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000444	0.00282	CcSEcCtD
Nateglinide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000438	0.00278	CcSEcCtD
Nateglinide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000438	0.00278	CcSEcCtD
Nateglinide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000435	0.00276	CcSEcCtD
Nateglinide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00043	0.00274	CcSEcCtD
Nateglinide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000429	0.00273	CcSEcCtD
Nateglinide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000423	0.00269	CcSEcCtD
Nateglinide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000423	0.00269	CcSEcCtD
Nateglinide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000419	0.00267	CcSEcCtD
Nateglinide—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000417	0.00265	CcSEcCtD
Nateglinide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000414	0.00264	CcSEcCtD
Nateglinide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000413	0.00263	CcSEcCtD
Nateglinide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000409	0.0026	CcSEcCtD
Nateglinide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000409	0.0026	CcSEcCtD
Nateglinide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000401	0.00255	CcSEcCtD
Nateglinide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.0004	0.00254	CcSEcCtD
Nateglinide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000393	0.0025	CcSEcCtD
Nateglinide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000393	0.0025	CcSEcCtD
Nateglinide—Rash—Formoterol—chronic obstructive pulmonary disease	0.00039	0.00248	CcSEcCtD
Nateglinide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00039	0.00248	CcSEcCtD
Nateglinide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00039	0.00248	CcSEcCtD
Nateglinide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00039	0.00248	CcSEcCtD
Nateglinide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000386	0.00246	CcSEcCtD
Nateglinide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000385	0.00245	CcSEcCtD
Nateglinide—Rash—Montelukast—chronic obstructive pulmonary disease	0.000382	0.00243	CcSEcCtD
Nateglinide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000382	0.00243	CcSEcCtD
Nateglinide—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000374	0.00238	CcSEcCtD
Nateglinide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000371	0.00236	CcSEcCtD
Nateglinide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000368	0.00234	CcSEcCtD
Nateglinide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000368	0.00234	CcSEcCtD
Nateglinide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000367	0.00234	CcSEcCtD
Nateglinide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000367	0.00234	CcSEcCtD
Nateglinide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00036	0.00229	CcSEcCtD
Nateglinide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000347	0.00221	CcSEcCtD
Nateglinide—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000324	0.00206	CcSEcCtD
Nateglinide—Amphetamine—SLC6A4—chronic obstructive pulmonary disease	0.000314	0.0459	CrCbGaD
Nateglinide—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000309	0.00197	CcSEcCtD
Nateglinide—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000298	0.0019	CcSEcCtD
Nateglinide—Methamphetamine—SLC6A4—chronic obstructive pulmonary disease	0.000291	0.0426	CrCbGaD
Nateglinide—ABCC8—smooth muscle tissue—chronic obstructive pulmonary disease	0.00029	0.0652	CbGeAlD
Nateglinide—PPARG—respiratory system—chronic obstructive pulmonary disease	0.000274	0.0618	CbGeAlD
Nateglinide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000266	0.00169	CcSEcCtD
Nateglinide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000247	0.00157	CcSEcCtD
Nateglinide—PPARG—connective tissue—chronic obstructive pulmonary disease	0.000242	0.0544	CbGeAlD
Nateglinide—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000235	0.0015	CcSEcCtD
Nateglinide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000221	0.00141	CcSEcCtD
Nateglinide—PPARG—smooth muscle tissue—chronic obstructive pulmonary disease	0.000221	0.0498	CbGeAlD
Nateglinide—SLC15A2—respiratory system—chronic obstructive pulmonary disease	0.000215	0.0484	CbGeAlD
Nateglinide—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000214	0.00136	CcSEcCtD
Nateglinide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000211	0.00134	CcSEcCtD
Nateglinide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000211	0.00134	CcSEcCtD
Nateglinide—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.00021	0.00133	CcSEcCtD
Nateglinide—ABCC4—bronchus—chronic obstructive pulmonary disease	0.000205	0.0462	CbGeAlD
Nateglinide—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000199	0.00127	CcSEcCtD
Nateglinide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000199	0.00127	CcSEcCtD
Nateglinide—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000193	0.00123	CcSEcCtD
Nateglinide—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000192	0.00122	CcSEcCtD
Nateglinide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000179	0.00114	CcSEcCtD
Nateglinide—SLC15A2—bronchus—chronic obstructive pulmonary disease	0.000177	0.0398	CbGeAlD
Nateglinide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000175	0.00111	CcSEcCtD
Nateglinide—SLC16A1—lung—chronic obstructive pulmonary disease	0.000174	0.0391	CbGeAlD
Nateglinide—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000172	0.0011	CcSEcCtD
Nateglinide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000167	0.00106	CcSEcCtD
Nateglinide—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.000163	0.0368	CbGeAlD
Nateglinide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000161	0.00102	CcSEcCtD
Nateglinide—SLC15A2—trachea—chronic obstructive pulmonary disease	0.000159	0.0358	CbGeAlD
Nateglinide—ORM1—lung—chronic obstructive pulmonary disease	0.000156	0.0351	CbGeAlD
Nateglinide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000155	0.000984	CcSEcCtD
Nateglinide—Rash—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000976	CcSEcCtD
Nateglinide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000975	CcSEcCtD
Nateglinide—PTGS1—respiratory system—chronic obstructive pulmonary disease	0.000147	0.0331	CbGeAlD
Nateglinide—PPARG—lung—chronic obstructive pulmonary disease	0.000146	0.0328	CbGeAlD
Nateglinide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000145	0.00092	CcSEcCtD
Nateglinide—ABCC4—lung—chronic obstructive pulmonary disease	0.000132	0.0298	CbGeAlD
Nateglinide—PTGS1—connective tissue—chronic obstructive pulmonary disease	0.000129	0.0291	CbGeAlD
Nateglinide—PTGS1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000118	0.0266	CbGeAlD
Nateglinide—SLC15A2—lung—chronic obstructive pulmonary disease	0.000114	0.0257	CbGeAlD
Nateglinide—PTGS1—trachea—chronic obstructive pulmonary disease	0.000108	0.0244	CbGeAlD
Nateglinide—CYP3A5—lung—chronic obstructive pulmonary disease	8.67e-05	0.0195	CbGeAlD
Nateglinide—PTGS1—lung—chronic obstructive pulmonary disease	7.79e-05	0.0176	CbGeAlD
Nateglinide—SLC22A6—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	5.38e-05	0.000615	CbGpPWpGaD
Nateglinide—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.38e-05	0.000615	CbGpPWpGaD
Nateglinide—UGT1A9—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	5.36e-05	0.000612	CbGpPWpGaD
Nateglinide—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.36e-05	0.000611	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	5.35e-05	0.000611	CbGpPWpGaD
Nateglinide—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.31e-05	0.000606	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.27e-05	0.000602	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.23e-05	0.000598	CbGpPWpGaD
Nateglinide—PPARG—Adipogenesis—IL6—chronic obstructive pulmonary disease	5.16e-05	0.000589	CbGpPWpGaD
Nateglinide—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.12e-05	0.000585	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.12e-05	0.000584	CbGpPWpGaD
Nateglinide—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.06e-05	0.000578	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.03e-05	0.000575	CbGpPWpGaD
Nateglinide—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.99e-05	0.00057	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—GCLC—chronic obstructive pulmonary disease	4.97e-05	0.000568	CbGpPWpGaD
Nateglinide—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	4.95e-05	0.000565	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	4.95e-05	0.000565	CbGpPWpGaD
Nateglinide—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.95e-05	0.000565	CbGpPWpGaD
Nateglinide—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	4.94e-05	0.000564	CbGpPWpGaD
Nateglinide—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.92e-05	0.000562	CbGpPWpGaD
Nateglinide—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	4.91e-05	0.00056	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.9e-05	0.00056	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.89e-05	0.000558	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.88e-05	0.000557	CbGpPWpGaD
Nateglinide—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.88e-05	0.000557	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	4.88e-05	0.000557	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—ALB—chronic obstructive pulmonary disease	4.87e-05	0.000556	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	4.85e-05	0.000554	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—GCLC—chronic obstructive pulmonary disease	4.82e-05	0.000551	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.81e-05	0.000549	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—MMP1—chronic obstructive pulmonary disease	4.79e-05	0.000547	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	4.77e-05	0.000545	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—GCLC—chronic obstructive pulmonary disease	4.75e-05	0.000543	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.75e-05	0.000543	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—LEP—chronic obstructive pulmonary disease	4.75e-05	0.000543	CbGpPWpGaD
Nateglinide—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.73e-05	0.00054	CbGpPWpGaD
Nateglinide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	4.72e-05	0.000539	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.71e-05	0.000538	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—PLAU—chronic obstructive pulmonary disease	4.7e-05	0.000537	CbGpPWpGaD
Nateglinide—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.69e-05	0.000535	CbGpPWpGaD
Nateglinide—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.67e-05	0.000533	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—NOS3—chronic obstructive pulmonary disease	4.66e-05	0.000532	CbGpPWpGaD
Nateglinide—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.63e-05	0.000528	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	4.62e-05	0.000528	CbGpPWpGaD
Nateglinide—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	4.61e-05	0.000526	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.56e-05	0.00052	CbGpPWpGaD
Nateglinide—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	4.54e-05	0.000519	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—CTGF—chronic obstructive pulmonary disease	4.54e-05	0.000518	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	4.45e-05	0.000509	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.44e-05	0.000506	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.41e-05	0.000504	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—CTGF—chronic obstructive pulmonary disease	4.4e-05	0.000503	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	4.36e-05	0.000498	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.34e-05	0.000495	CbGpPWpGaD
Nateglinide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	4.33e-05	0.000494	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	4.33e-05	0.000494	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—NOS2—chronic obstructive pulmonary disease	4.32e-05	0.000493	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.3e-05	0.000491	CbGpPWpGaD
Nateglinide—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.26e-05	0.000486	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.21e-05	0.000481	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.2e-05	0.00048	CbGpPWpGaD
Nateglinide—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.2e-05	0.000479	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—CTGF—chronic obstructive pulmonary disease	4.18e-05	0.000478	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.18e-05	0.000478	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.06e-05	0.000463	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4e-05	0.000456	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	3.99e-05	0.000456	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	3.98e-05	0.000454	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.97e-05	0.000453	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	3.96e-05	0.000452	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	3.93e-05	0.000449	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—HDAC2—chronic obstructive pulmonary disease	3.9e-05	0.000445	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	3.81e-05	0.000435	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	3.77e-05	0.000431	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	3.75e-05	0.000428	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.69e-05	0.000421	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	3.64e-05	0.000416	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	3.64e-05	0.000415	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—ALB—chronic obstructive pulmonary disease	3.63e-05	0.000414	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.61e-05	0.000412	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—GCLC—chronic obstructive pulmonary disease	3.57e-05	0.000407	CbGpPWpGaD
Nateglinide—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.55e-05	0.000405	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.55e-05	0.000405	CbGpPWpGaD
Nateglinide—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.5e-05	0.0004	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.49e-05	0.000398	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—NOS3—chronic obstructive pulmonary disease	3.47e-05	0.000396	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	3.45e-05	0.000394	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.44e-05	0.000393	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.43e-05	0.000391	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.38e-05	0.000386	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	3.36e-05	0.000384	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—VEGFA—chronic obstructive pulmonary disease	3.36e-05	0.000383	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.34e-05	0.000381	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.33e-05	0.000381	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.32e-05	0.00038	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.29e-05	0.000375	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.29e-05	0.000375	CbGpPWpGaD
Nateglinide—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.26e-05	0.000373	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—CTGF—chronic obstructive pulmonary disease	3.25e-05	0.000371	CbGpPWpGaD
Nateglinide—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.22e-05	0.000367	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.21e-05	0.000366	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.21e-05	0.000366	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	3.19e-05	0.000365	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.17e-05	0.000362	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.14e-05	0.000359	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.11e-05	0.000355	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.1e-05	0.000354	CbGpPWpGaD
Nateglinide—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.09e-05	0.000353	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—TGFB1—chronic obstructive pulmonary disease	3.08e-05	0.000352	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.06e-05	0.00035	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—GCLC—chronic obstructive pulmonary disease	3.06e-05	0.00035	CbGpPWpGaD
Nateglinide—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.05e-05	0.000349	CbGpPWpGaD
Nateglinide—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.05e-05	0.000348	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.04e-05	0.000347	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	3.03e-05	0.000346	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.03e-05	0.000346	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3e-05	0.000342	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GC—chronic obstructive pulmonary disease	2.97e-05	0.000339	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.95e-05	0.000336	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.9e-05	0.000332	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—MMP9—chronic obstructive pulmonary disease	2.86e-05	0.000326	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.86e-05	0.000326	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CTGF—chronic obstructive pulmonary disease	2.8e-05	0.000319	CbGpPWpGaD
Nateglinide—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.76e-05	0.000315	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.74e-05	0.000312	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.69e-05	0.000307	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.61e-05	0.000298	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	2.58e-05	0.000294	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.58e-05	0.000294	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	2.56e-05	0.000293	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—TP53—chronic obstructive pulmonary disease	2.54e-05	0.000289	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.53e-05	0.000288	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.52e-05	0.000288	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—VEGFA—chronic obstructive pulmonary disease	2.5e-05	0.000286	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.5e-05	0.000285	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.5e-05	0.000285	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.5e-05	0.000285	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.49e-05	0.000284	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.48e-05	0.000283	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.47e-05	0.000281	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	2.45e-05	0.00028	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.43e-05	0.000278	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.37e-05	0.00027	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.35e-05	0.000269	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	2.35e-05	0.000268	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.33e-05	0.000266	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.31e-05	0.000264	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.3e-05	0.000262	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—TGFB1—chronic obstructive pulmonary disease	2.3e-05	0.000262	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.28e-05	0.00026	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.28e-05	0.00026	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.26e-05	0.000258	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.2e-05	0.000251	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.2e-05	0.000251	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	2.2e-05	0.000251	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.18e-05	0.000249	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	2.17e-05	0.000247	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.17e-05	0.000247	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.15e-05	0.000245	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	2.13e-05	0.000243	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.12e-05	0.000242	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.1e-05	0.00024	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—ALB—chronic obstructive pulmonary disease	2.07e-05	0.000236	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	2.02e-05	0.00023	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—ALB—chronic obstructive pulmonary disease	2e-05	0.000229	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—NOS3—chronic obstructive pulmonary disease	1.98e-05	0.000226	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.97e-05	0.000225	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—ALB—chronic obstructive pulmonary disease	1.97e-05	0.000225	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.95e-05	0.000223	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—NOS3—chronic obstructive pulmonary disease	1.92e-05	0.000219	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.91e-05	0.000218	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—TP53—chronic obstructive pulmonary disease	1.89e-05	0.000216	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.89e-05	0.000216	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.88e-05	0.000215	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.87e-05	0.000214	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.86e-05	0.000213	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.81e-05	0.000206	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.8e-05	0.000206	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.78e-05	0.000203	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.77e-05	0.000203	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.75e-05	0.0002	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.73e-05	0.000197	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.7e-05	0.000194	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.66e-05	0.00019	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.65e-05	0.000188	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.65e-05	0.000188	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.62e-05	0.000185	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.61e-05	0.000184	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.6e-05	0.000183	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.6e-05	0.000183	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.57e-05	0.00018	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.57e-05	0.000179	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.57e-05	0.000179	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.53e-05	0.000174	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.49e-05	0.00017	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—ALB—chronic obstructive pulmonary disease	1.48e-05	0.000169	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.46e-05	0.000167	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—NOS3—chronic obstructive pulmonary disease	1.42e-05	0.000162	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.35e-05	0.000154	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.34e-05	0.000153	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.33e-05	0.000152	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.32e-05	0.000151	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.31e-05	0.00015	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.31e-05	0.000149	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.29e-05	0.000147	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—ALB—chronic obstructive pulmonary disease	1.27e-05	0.000145	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.22e-05	0.00014	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.22e-05	0.000139	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.21e-05	0.000138	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.2e-05	0.000137	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.2e-05	0.000137	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.14e-05	0.00013	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.13e-05	0.000129	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.12e-05	0.000128	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.11e-05	0.000127	CbGpPWpGaD
Nateglinide—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.11e-05	0.000127	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.1e-05	0.000126	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	1.07e-05	0.000122	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.04e-05	0.000119	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	1.04e-05	0.000118	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.03e-05	0.000118	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	1.02e-05	0.000117	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.92e-06	0.000113	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.8e-06	0.000112	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.29e-06	0.000106	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.21e-06	0.000105	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.16e-06	0.000105	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.08e-06	0.000104	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.76e-06	0.0001	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	8.66e-06	9.89e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	8.55e-06	9.77e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.53e-06	9.74e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.46e-06	9.66e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.09e-06	9.24e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.02e-06	9.16e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	7.9e-06	9.02e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	7.73e-06	8.83e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	7.4e-06	8.45e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.28e-06	8.31e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	6.37e-06	7.27e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.07e-06	6.93e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.99e-06	6.84e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.58e-06	6.37e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	5.5e-06	6.28e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	5.45e-06	6.22e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.29e-06	6.04e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.26e-06	6.01e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	5.21e-06	5.95e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.6e-06	4.11e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.44e-06	3.93e-05	CbGpPWpGaD
